Celadon Pharmaceuticals Plc (CEL.L)
GBp 4.5
(0.0%)
GBp 4.5
(0.0%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 75 Thousand GBP | -619.7% |
| 2022 | -66 Thousand GBP | -560.0% |
| 2021 | -10 Thousand GBP | 0.0% |
| 2020 | - GBP | 0.0% |
| 2019 | - GBP | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | 6000.00 GBP | -55.56% |
| 2024 Q2 | 6000.00 GBP | 0.0% |
| 2023 Q2 | -286 Thousand GBP | -2100.0% |
| 2023 FY | -475 Thousand GBP | -619.7% |
| 2023 Q3 | 13.5 Thousand GBP | 104.72% |
| 2023 Q1 | -13 Thousand GBP | 96.27% |
| 2023 Q4 | 13.5 Thousand GBP | 0.0% |
| 2022 Q2 | -183.17 Thousand GBP | -2952.85% |
| 2022 Q1 | -6000.00 GBP | -20.0% |
| 2022 FY | -66 Thousand GBP | -560.0% |
| 2022 Q4 | -348.82 Thousand GBP | -1191.96% |
| 2022 Q3 | -27 Thousand GBP | 85.26% |
| 2021 FY | -10 Thousand GBP | 0.0% |
| 2021 Q2 | - GBP | 0.0% |
| 2021 Q4 | -5000.00 GBP | 0.0% |
| 2021 Q1 | - GBP | 0.0% |
| 2021 Q3 | -5000.00 GBP | 0.0% |
| 2020 Q4 | - GBP | 0.0% |
| 2020 Q2 | - GBP | 0.0% |
| 2020 Q1 | - GBP | 0.0% |
| 2020 FY | - GBP | 0.0% |
| 2020 Q3 | - GBP | 0.0% |
| 2019 Q3 | - GBP | 0.0% |
| 2019 FY | - GBP | 0.0% |
| 2019 Q1 | - GBP | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|